Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ADMA

ADMA Biologics

$4.05

-0.01 (-0.25%)

07:50
08/22/19
08/22
07:50
08/22/19
07:50
Hot Stocks
ADMA Biologics announces commercial relaunch of BIVIGAM »

ADMA Biologics announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

Over a month ago
ADMA

ADMA Biologics

$3.72

0.23 (6.59%)

13:49
08/12/19
08/12
13:49
08/12/19
13:49
Downgrade
ADMA Biologics rating change at Dawson James »

ADMA Biologics downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

ADMA

ADMA Biologics

$3.35

0.16 (5.02%)

07:30
08/08/19
08/08
07:30
08/08/19
07:30
Earnings
ADMA Biologics reports Q2 EPS (25c), consensus (29c) »

Reports Q2 revenue $6.6M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

ADMA

ADMA Biologics

$3.77

0.18 (5.01%)

08:59
07/09/19
07/09
08:59
07/09/19
08:59
Recommendations
ADMA Biologics analyst commentary at Jefferies »

ADMA Biologics shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMA

ADMA Biologics

$3.59

-0.13 (-3.49%)

08:28
07/08/19
07/08
08:28
07/08/19
08:28
Hot Stocks
ADMA Biologics receives FDA approval for license transfers for BIVIGAM, Nabi-HB »

ADMA Biologics announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
ADMA

ADMA Biologics

$4.19

0.04 (0.96%)

08:40
06/04/19
06/04
08:40
06/04/19
08:40
Initiation
ADMA Biologics initiated at Jefferies »

ADMA Biologics initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 05

    Jun

CRAY

Cray

$29.80

0.22 (0.74%)

, HPE

HP Enterprise

$14.55

0.12 (0.83%)

09:03
05/17/19
05/17
09:03
05/17/19
09:03
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Cray (CRAY), up…

CRAY

Cray

$29.80

0.22 (0.74%)

HPE

HP Enterprise

$14.55

0.12 (0.83%)

DE

Deere

$145.97

1.16 (0.80%)

PINS

Pinterest

$26.01

-2.66 (-9.28%)

BIDU

Baidu

$138.50

-13.95 (-9.15%)

ADMA

ADMA Biologics

$4.32

-0.15 (-3.36%)

UA

Under Armour

$19.45

0.5 (2.64%)

UAA

Under Armour

$22.04

0.68 (3.18%)

ACHN

Achillion

$3.05

0.005 (0.16%)

MTNB

Matinas BioPharma

$0.94

0.0228 (2.48%)

AMAT

Applied Materials

$44.28

2.78 (6.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    May

  • 23

    May

  • 28

    May

  • 29

    May

  • 29

    May

  • 30

    May

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 11

    Jun

  • 09

    Jul

  • 17

    Jul

  • 17

    May

ADMA

ADMA Biologics

$4.32

-0.15 (-3.36%)

07:32
05/17/19
05/17
07:32
05/17/19
07:32
Syndicate
ADMA Biologics 11.25M share Secondary priced at $4.00 »

Jefferies acted as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 17

    May

ADMA

ADMA Biologics

$4.47

0.08 (1.82%)

16:37
05/15/19
05/15
16:37
05/15/19
16:37
Syndicate
ADMA Biologics files to sell $45M of common stock »

Jefferies is acting as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

ADMA

ADMA Biologics

$5.16

0.14 (2.79%)

07:04
05/10/19
05/10
07:04
05/10/19
07:04
Hot Stocks
ADMA Biologics: FDA approves PAS for BIVIGAM »

ADMA Biologics announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.